Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 85 Issue 1, January 2019

Otani et al. used human amniotic fluid stem cells to ameliorate chronic damage from hypoxia-ischemia, using a mouse model. See the article on page 97

Editor's Focus

Top of page ⤴

Editorial

Top of page ⤴

Comment

Top of page ⤴

Insights

Top of page ⤴

Review Article

Top of page ⤴

Population Study Article

Top of page ⤴

Clinical Research Article

Top of page ⤴

Basic Science Article

Top of page ⤴

Search

Quick links